REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Crism Therapeutics Corp. (United Kingdom)

Main Activities: Copper, Nickel, Lead, and Zinc Mining
Full name: Crism Therapeutics Corp. Profile Updated: August 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Amur Minerals Corporation (LON:AMC) is a nickel copper sulphide mineral exploration company focused on the far east of Russia, is registered in the UK. The company's principal asset is the Kun-Manie sulphide nickel, copper project located in Amur Oblast. The Kun-Manie project is the largest undeveloped and drill proven nickel copper sulphide deposit in Asia.

Headquarters
One Nex, 4th Floor, 1 Royal Exchange Avenue
Tortola; British Virgin Islands;

Contact Details: Purchase the Crism Therapeutics Corp. report to view the information.

Website: http://www.amurminerals.com

Basic Information
Total Employees:
Purchase the Crism Therapeutics Corp. report to view the information.
Outstanding Shares:
Purchase the Crism Therapeutics Corp. report to view the information.
Financial Auditors:
Purchase the Crism Therapeutics Corp. report to view the information.
Incorporation Date:
January 14, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
18.63%
Purchase this report to view the information.
15.02%
Purchase this report to view the information.
15.02%
Purchase this report to view the information.
15.02%
Purchase this report to view the information.
4.52%
Subsidiaries
Irosta Trading Limited (Cyprus)
100%
Company Performance
Financial values in the chart are available after Crism Therapeutics Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency GBP. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-282.76%▼
EBITDA
-289.79%▼
Net Profit (Loss) for the Period
-8947.03%▼
Total Assets
-9.4%▼
Total Equity
-19.99%▼
Return on Equity (ROE)
-70.36%▼
Quick Ratio
-2.91%▼
Cash Ratio
-4.48%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo